2023
DOI: 10.1007/s12272-023-01444-3
|View full text |Cite
|
Sign up to set email alerts
|

EGF, a veteran of wound healing: highlights on its mode of action, clinical applications with focus on wound treatment, and recent drug delivery strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 156 publications
0
2
0
Order By: Relevance
“…In the process of wound repair, the functions of growth factors include [9,10]: (1) Guide neutrophils and macrophages into the wound area to clear the necrotic tissue; (2) Promote proliferation of fibronuclear epidermal cells; (3) Promote the synthesis and release of the body's growth factors; (4) Elevate the formation of granulation tissue; (5) Promote the synthesis and accumulation of extracellular interstitial molecules; (6) Inhibit scar tissue hyperplasia. Among them, EGF has a strong ability to promote wound healing, promote cell division, promote the synthesis of extracellular matrix such as hyaluronic acid, fibulnexin, glycoprotein and hydroxyproline acid, and thus reduce scar hyperplasia [11].…”
Section: Introductionmentioning
confidence: 99%
“…In the process of wound repair, the functions of growth factors include [9,10]: (1) Guide neutrophils and macrophages into the wound area to clear the necrotic tissue; (2) Promote proliferation of fibronuclear epidermal cells; (3) Promote the synthesis and release of the body's growth factors; (4) Elevate the formation of granulation tissue; (5) Promote the synthesis and accumulation of extracellular interstitial molecules; (6) Inhibit scar tissue hyperplasia. Among them, EGF has a strong ability to promote wound healing, promote cell division, promote the synthesis of extracellular matrix such as hyaluronic acid, fibulnexin, glycoprotein and hydroxyproline acid, and thus reduce scar hyperplasia [11].…”
Section: Introductionmentioning
confidence: 99%
“…Among these, EGF was employed in wound management and regenerative medicine since the late 1980s. Its widespread and enduring utilization is attributable to its exceptional tolerability and effectiveness [20].…”
Section: Introductionmentioning
confidence: 99%
“…EGF stimulates keratinocyte proliferation and migration via a paracrine mechanism [ 1 , 3 , 6 ]. The proliferation and migration of keratinocytes, key events in skin wound healing, are induced through the activation of the phosphoinositide 3-kinases (PI3K)/protein kinase B (AKT) and mitogen-activated protein kinase kinases (MAPKs), which are EGF receptor signaling pathways [ 7 , 8 , 9 , 10 ]. EGF is found in many different sources, such as urine, tears, saliva, milk, and plasma [ 1 ]; however, it is difficult to isolate and purify from these sources, and EGF itself is not sufficiently stable for use in medical or cosmetic applications.…”
Section: Introductionmentioning
confidence: 99%
“…EGF is found in many different sources, such as urine, tears, saliva, milk, and plasma [ 1 ]; however, it is difficult to isolate and purify from these sources, and EGF itself is not sufficiently stable for use in medical or cosmetic applications. To overcome these drawbacks, many researchers have attempted to develop EGF delivery systems [ 9 , 11 , 12 , 13 ] and stable molecules that directly or indirectly activate EGF receptors [ 14 , 15 ]. G-protein-coupled receptor (GPCR) ligands, including lysophosphatidic acid (LPA), transactivate the EGF receptor by enhancing the tyrosine phosphorylation of the EGF receptor and stimulating the proliferation of keratinocytes [ 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%